GPT Healthcare Price to Sales Ratio (P/S)

GPT Healthcare Ltd Price to Sales Ratio

The GPT Healthcare Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate GPT Healthcare Ltd's valuation, profitability, and overall financial performance. Tracking the GPT Healthcare Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

GPT Healthcare Ltd (NSE: GPTHEALTH, BSE: 544131) is currently trading at ₹124.60, with a market capitalization of ₹10.11B. As a leading company in the Health services sector and Hospital/Nursing management industry, monitoring the GPT Healthcare Ltd Price to Sales Ratio is essential for fundamental analysis.

GPT Healthcare Ltd Price to Sales Ratio Current Value

The current GPT Healthcare Ltd Price to Sales Ratio stands at 2.96.

The GPT Healthcare Ltd Price to Sales Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

GPT Healthcare Ltd Price to Sales Ratio Historical Trend

The GPT Healthcare Ltd Price to Sales Ratio has shown the following historical trend:

• 2024: 2.96
• 2023: 3.54
• 2020: 0
• 2019: 0
• 2018: 0

The decline in GPT Healthcare Ltd Price to Sales Ratio indicates improving financial efficiency or better earnings growth.

What GPT Healthcare Ltd Price to Sales Ratio Indicates for Investors

The GPT Healthcare Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/S ratio helps evaluate valuation relative to company revenue.

GPT Healthcare Ltd Price to Sales Ratio Analysis Summary

The GPT Healthcare Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking GPT Healthcare Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of GPT Healthcare Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.